WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998048630) METHOD OF TREATING MALIGNANCIES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/048630    International Application No.:    PCT/US1998/008835
Publication Date: 05.11.1998 International Filing Date: 30.04.1998
Chapter 2 Demand Filed:    18.11.1998    
IPC:
A61K 31/704 (2006.01), A61K 33/24 (2006.01), A61K 35/12 (2006.01), A61K 35/14 (2006.01), A61K 45/00 (2006.01), A61P 35/00 (2006.01), A61P 43/00 (2006.01), C12N 5/09 (2010.01), A61K 38/00 (2006.01)
Applicants: THE WISTAR INSTITUTE OF ANATOMY & BIOLOGY [US/US]; 3601 Spruce Street, Philadelphia, PA 19104-4268 (US) (AT, AU, BE, CA, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, JP, LU, MC, NL, PT, SE only).
SANTOLI, Daniela [US/US]; (US) (For US Only).
ROVERA, Giovanni [US/US]; (US) (For US Only).
CESANO, Alessandra [IT/US]; (US) (For US Only)
Inventors: SANTOLI, Daniela; (US).
ROVERA, Giovanni; (US).
CESANO, Alessandra; (US)
Agent: BAK, Mary, E.; Howson and Howson, Spring House Corporate Center, P.O. Box 457, Spring House, PA 19477 (US)
Priority Data:
08/847,000 01.05.1997 US
Title (EN) METHOD OF TREATING MALIGNANCIES
(FR) PROCEDE DE TRAITEMENT DES TUMEURS MALIGNES
Abstract: front page image
(EN)Use of a synergistic combination of chemotherapy and cell therapy with cells of a stable cell line characterized by non-MHC restricted cytotoxic activity in a method of treating tumors. The method of the invention permits reduced amounts of chemotherapeutic agents to be administered, resulting in a reduction of the side effects often associated therewith.
(FR)L'invention porte sur un procédé de traitement des tumeurs par combinaison synergique de chimiothérapie et d'une thérapie cellulaire utilisant des cellules de lignées de cellules stabilisées à activité cytotoxique non réduite par le CMH. Ladite méthode permet de réduire les doses d'agents chimiothérapeutiques à administrer et par là les effets secondaires souvent associés.
Designated States: AU, CA, JP, US.
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)